Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality

Sandeep Budhiraja, Abhaya Indrayan, Poonam Das, Arun Dewan, Omender Singh, Vivek Nangia, Y P Singh, Rajesh Pandey, Ajay Kumar Gupta, Manish Gupta, Deepak Bhasin, Bhupesh Uniyal, Mohit Mathur, Mayur Pawar
doi: https://doi.org/10.1101/2021.12.24.21268371
Sandeep Budhiraja
1Clinical Directorate and Dept of Internal Medicine, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sbudhiraja@maxhealthcare.com
Abhaya Indrayan
2Division of Biostatistics, Clinical Directorate, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Poonam Das
3Dept of Laboratory Medicine, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arun Dewan
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omender Singh
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivek Nangia
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y P Singh
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Pandey
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajay Kumar Gupta
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Gupta
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepak Bhasin
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bhupesh Uniyal
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohit Mathur
4Dept of Critical Care, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayur Pawar
2Division of Biostatistics, Clinical Directorate, Max Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Various inflammatory markers are commonly assessed in many patients to help in the management of COVID-19 patients. It is not clear, though, how much risk of mortality their different levels of elevations entail, and which marker signifies more risk than others and how much. This study was undertaken to describe their levels and to answer these questions regarding eight inflammatory markers, namely, CRP, D-dimer, ferritin, IL-6, LDH, CPK, troponin-I.

Methods The data were retrieved from the electronic records of 19852 CoViD-19 patients admitted to a chain of hospitals in north India from March 2020 to July 2021. Levels for most markers were available for more than 10,000 patients. In view of widely different ranges of values of different markers, we divided their values into quintiles (Qs) and studied the pattern of mortality and for running the logistic regression. In addition, logarithm transformation was also tried. The statistical distribution of the values was compared by Mann-Whitney test. Relative importance was judged by the mortality rates, area under the ROC curves (AUROCs), and the odds ratios.

Results Although the mortality increased with decreasing ALC and increasing level of all the other markers, more than 70% survived even with levels in the extreme quintile. The adjusted odds ratio was the highest (7.62) for the Q5 levels of IL-6, closely followed by D-dimer (OR = 6.04). The AUROC was the highest (0.817) for LDH and the least (0.612) for CPK. However, the optimal cut-off for any marker could correctly classify not more than 80% deaths and the multivariable logistic regression could correctly classify patients with mortality in less than 24% cases.

Conclusion Although elevated levels of all the markers and low values of ALC were significant risk factor but no firm evidence was available for any of the eight markers to be a major indicator of the mortality in COVID-19 unless they reach to a critical threshold. Among those studied, D-Dimer (>192 ng/mL) followed by IL-6 (>4.5 pg/mL) had stronger association with mortality even with moderate and higher end of the normal levels and LDH (>433 U/L) and troponin-I (>0.002ng/mL) with only steeply increased levels. Ferritin had modest association, and CPK, CRP and ALC were a relatively poor risk of mortality.

Competing Interest Statement

None of the authors reported any conflict of interest.

Funding Statement

This study did not receive any financial contribution from any funding agency/source.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Ethics Committee, Max Super Speciality Hospital (A unit of Devki Devi Foundation), Address: Service Floor, Office of Ethics Committee, East Block, next to Conference Room, Max Super Speciality Hospital, Saket (A unit of Devki Devi Foundation), 2, Press Enclave Road, Saket, New Delhi 110017 vide ref. no. BHRRSMSSHDDFSKT2IECIM21 32 dated 23rd December 2021. The IEC provided no objection and approved the publication of this manuscript.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced are available online at EHR

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
Sandeep Budhiraja, Abhaya Indrayan, Poonam Das, Arun Dewan, Omender Singh, Vivek Nangia, Y P Singh, Rajesh Pandey, Ajay Kumar Gupta, Manish Gupta, Deepak Bhasin, Bhupesh Uniyal, Mohit Mathur, Mayur Pawar
medRxiv 2021.12.24.21268371; doi: https://doi.org/10.1101/2021.12.24.21268371
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
Sandeep Budhiraja, Abhaya Indrayan, Poonam Das, Arun Dewan, Omender Singh, Vivek Nangia, Y P Singh, Rajesh Pandey, Ajay Kumar Gupta, Manish Gupta, Deepak Bhasin, Bhupesh Uniyal, Mohit Mathur, Mayur Pawar
medRxiv 2021.12.24.21268371; doi: https://doi.org/10.1101/2021.12.24.21268371

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (158)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8547)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1742)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10279)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1669)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1762)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (519)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)